We are live on ! Find out more
MDXG icon

MiMedx Group

209 hedge funds and large institutions have $1.02B invested in MiMedx Group in 2017 Q2 according to their latest regulatory filings, with 47 funds opening new positions, 79 increasing their positions, 51 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

262% more first-time investments, than exits

New positions opened: 47 | Existing positions closed: 13

100% more funds holding in top 10

Funds holding in top 10: 24 (+2)

72% more capital invested

Capital invested by funds: $591M → $1.02B (+$427M)

55% more repeat investments, than reductions

Existing positions increased: 79 | Existing positions reduced: 51

19% more funds holding

Funds holding: 176209 (+33)

16% more call options, than puts

Call options by funds: $22.1M | Put options by funds: $19.1M

Holders
209
Holders Change
+33
Holders Change %
+18.75%
% of All Funds
5.21%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.1%
New
47
Increased
79
Reduced
51
Closed
13
Calls
$22.1M
Puts
$19.1M
Net Calls
+$3.04M
Net Calls Change
+$15.9M
Name Holding Trade Value Shares
Change
Change in
Stake
Goldman Sachs
26
Goldman Sachs
New York
$8.65M +$5.08M +380,705 +193%
PP
27
PDT Partners
New York
$7.6M +$6.77M +507,463 New
Millennium Management
28
Millennium Management
New York
$7.4M +$6.37M +477,435 +2,876%
Renaissance Technologies
29
Renaissance Technologies
New York
$7.28M +$6.49M +486,400 New
Charles Schwab
30
Charles Schwab
California
$6.83M +$495K +37,117 +9%
GC
31
Guggenheim Capital
Illinois
$6.74M +$883K +66,213 +17%
PCM
32
Parsons Capital Management
Rhode Island
$6.18M -$2.75M -206,173 -33%
TCIM
33
TIAA CREF Investment Management
New York
$6.17M +$670K +50,183 +14%
MWM
34
Merriman Wealth Management
Washington
$6.09M -$2.12M -158,525 -28%
Morgan Stanley
35
Morgan Stanley
New York
$6.07M +$313K +23,433 +6%
Invesco
36
Invesco
Georgia
$5.75M +$728K +54,558 +17%
PCMI
37
Paradigm Capital Management Inc
New York
$5.67M -$17M -1,276,900 -77%
Russell Investments Group
38
Russell Investments Group
United Kingdom
$5.45M +$840K +62,972 +21%
QI
39
QS Investors
New York
$5.27M
MWP
40
MYCIO Wealth Partners
Pennsylvania
$5.16M -$45K -3,370 -1%
SCA
41
Summit Creek Advisors
Minnesota
$5.16M -$355K -26,572 -7%
TIM
42
Thompson Investment Management
Wisconsin
$5.12M -$689K -51,615 -13%
Bank of America
43
Bank of America
North Carolina
$4.18M +$460K +34,481 +14%
AllianceBernstein
44
AllianceBernstein
Tennessee
$3.8M +$1.21M +90,800 +56%
CCS
45
Crosspoint Capital Strategies
California
$3.69M +$3.29M +246,269 New
WMC
46
Westwood Management Corporation
Illinois
$3.67M
PPA
47
Parametric Portfolio Associates
Washington
$3.57M -$1.26M -94,587 -28%
TA
48
Teachers Advisors
New York
$3.44M +$212K +15,891 +7%
Royal Bank of Canada
49
Royal Bank of Canada
Ontario, Canada
$3.4M -$887K -66,473 -23%
Canada Life
50
Canada Life
Manitoba, Canada
$3.22M +$119K +8,933 +4%

MDXG Hedge Fund Activity: Q2 2017 in Review

209 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in MiMedx Group (MDXG) for Q2 2017, worth a combined $1.02B — up 72% from $591M a quarter earlier.

Buyers outnumbered sellers: 47 funds opened new MDXG positions and 13 closed out — a net gain of 34 holders — while 79 added to existing stakes and 51 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $47.4M. The largest seller was Mesirow Financial Investment Management - Fixed Income, exiting entirely with an estimated $17.6M sold.

  • 209 institutional investors held MiMedx Group (MDXG) as of Q2 2017, up from 176 in Q1 2017.
  • Funds reported $1.02B of MiMedx Group stock for Q2 2017, up 72% quarter-over-quarter.
  • 47 funds opened new MiMedx Group positions in Q2 2017 and 13 closed out, a net change of +34 holders.
  • The largest MiMedx Group buyer in Q2 2017 was Wellington Management Group, an estimated $47.4M added.
  • The largest MiMedx Group seller in Q2 2017 was Mesirow Financial Investment Management - Fixed Income, an estimated $17.6M sold.

Based on aggregated 13F filings for Q2 2017.